Effectiveness and Safety of Ibrutinib for Chronic Lymphocytic Leukemia in Routine Clinical Practice: 3-Year Follow-up of the Belgian Ibrutinib Real-World Data (BiRD) Study ανά Ann Janssens, Zwi N. Berneman, Fritz Offner, Sylvia Snauwaert, Philippe Mineur, Gaetan Vanstraelen, Stef Meers, Isabelle Spoormans, Dominique Bron, Isabelle Vande Broek, Charlotte Van Bogaert, Birgit De Beleyr, Ann Smet, Lasse Nielsen, Robert Wapenaar, Marc André

Λήψη πλήρους κειμένου